ASCO: Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies Jeff Burdine Date Published: June 3, 2022 Link: https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.e16501
